Guardion Health Sciences Adds Experienced Vice President and Chief Financial Officer to Executive Management Team

Newly-Appointed CFO Andrew Schmidt Brings Extensive and Wide-Ranging Public Company Experience San Diego, California, July 21, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has appointed Andrew C. Schmidt, 58, as Vice President and Chief Financial Officer of the Company. Mr. Schmidt joins Guardion with more […]

Read More

Wessanen has acquired Danival, a leading producer of locally sourced organic products with deep roots in South West France.

Wessanen and Hain Celestial have signed and closed an agreement for the purchase of Danival. Located in the South West of France, Danival is a leading brand in organic products based on fruits and vegetables sourced from France. It  has promoted sustainable local development since its creation 30 years ago. Today it employs about 120 […]

Read More

New committee comprises policy team, COVID-19, economic task forces

Jakarta The COVID-19 Handling and National Economic Recovery Committee, formed by President Joko Widodo through Presidential Regulation Number 82 of 2020, comprises three arms. According to a copy of the regulation received in Jakarta on Monday evening, the new committee consists of the Policy Committee, the COVID-19 Handling Task Force, and the National Economic Recovery and Transformation Task Force The Policy Committee is chaired by the Coordinating Minister for Economic Affairs and has six deputy chairmen — the Coordinating Minister for Maritime Affairs and Investment, the Coordinating Minister for Political, Legal…

Read More

Bio Farma upbeat about commencing Sinovac vaccine production in 2021

Jakarta Indonesia’s state-owned pharmaceutical holding, Bio Farma, is optimistic of starting production of the Chinese COVID-19 vaccine Sinovac in the first quarter (Q1) of 2021, if the third phase of the vaccine’s clinical trial runs smoothly. The third phase of the clinical trial, scheduled to run for six months, is expected to conclude by January 2021, Honesti Basyir, the president director of Bio Farma, noted in a statement here on Tuesday. “If the third stage of the clinical trial for the COVID-19 vaccine were to run smoothly, Bio Farma would…

Read More

Govt to focus attention on domestic products in healthcare spending

Jakarta The government will attach top priority to domestic products in its healthcare spending for handling the coronavirus disease (COVID-19) in an endeavor to drive domestic economic growth amid the pandemic. “National products must be given priority to have multiplier effects on the public,” Coordinating Minister for Economic Affairs Airlangga Hartarto stated here on Tuesday. The government will augment health spending, as it has allotted Rp87.55 trillion for handling the COVID-19 pandemic. Vaccines, drug availability, and antibodies have emerged as the keys to the effective handling of the SARS CoV-2…

Read More